ArticleACS medicinal chemistry letters2021

Discovery of Investigational Drug CT1812, an Antagonist of the Sigma-2 Receptor Complex for Alzheimer's Disease.

Gilbert M Rishton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.